RGT 5.17% 30.5¢ argent biopharma limited

knock knock, page-5

  1. 13,748 Posts.
    lightbulb Created with Sketch. 2302
    I am trying to recall all the details but the amount of product that was required to satisfy the contract was well within the production parameters. Again we have the legal requirement for MXC to announce they were unable to meet any contractual arrangements. That has not happened. I get the feeling that VC testing facilities were not up to scratch and that has caused some of the delays. Not acceptable of course. MXC may be sticking the course as the contract is seen to be viable - and lucrative. I put it out there that if EITHER party was not able to complete their part of the contract that we would have had that announcement of the cancellation already - and some time ago. That would be material information for both company's shareholders and the market in general.

 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.